Emergent Biosolutions, Inc.

EBS XNYS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

370M

Short interest (Jul 15)

20.0%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.35%

Available Shares

900K

Price Chart

Company Overview

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Company Info

Exchange: NYSE

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001367644

Asset Type: CS

Market Data

Market Cap: $374,589,108

Employees: 900

Status: Active

Short Interest

Current Borrow Fee 0.35%

Range: 0.35% - 0.35%

Available Shares 900K

Range: 400K - 1.2M

Recent Changes

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime